vyvanse.com Report : Visit Site

Technical data of the vyvanse.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host vyvanse.com. Currently, hosted in United States and its service provider is CERFnet .

the related websites

healthline.com golspiegolfclub.co.uk blakewells.co.uk mhra.gov.uk adhd-centre.com thebodyhealer.com walgreens.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Microsoft-IIS/8.5 containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

treatment: adhd & moderate to severe b.e.d. in adults ') we're sorry, but your web browser must have javascript enabled for you to use all of the sites functions menu home expand/collapse menu adhd in children (6–17) what is adhd? adhd symptoms in children adhd doctor discussion guide common questions about adhd vyvanse & children vyvanse & kids (6–12) getting started on vyvanse adhd resources tips and advice expand/collapse menu adhd in adults what is adhd? adhd symptoms in adults adhd doctor discussion guide common questions about adhd vyvanse & adults getting started on vyvanse adhd resources everyday tips expand/collapse menu moderate to severe binge eating disorder in adults what is binge eating disorder? binge eating disorder symptom checklist vyvanse for adults with moderate to severe binge eating disorder talking with your doctor support for adults side effects for vyvanse prescribing information medication guide health care professionals vyvanse is a prescription medicine used for the treatment of attention-deficit/hyperactivity disorder (adhd) in patients 6 years and above, and for the treatment of moderate to severe binge eating disorder (b.e.d.) in adults. vyvanse is not for weight loss. it is not known if vyvanse is safe and effective for the treatment of obesity. important safety information vyvanse is a federally controlled substance (cii) because it can be abused or lead to dependence. keep vyvanse in a safe place to prevent misuse and abuse. selling or giving away vyvanse may harm others and is against the law. safety information continued below this site is intended for us audiences. ask your doctor if vyvanse is right for you. adhd in children (ages 6–17) get informed adhd in adults get started moderate to severe binge eating disorder in adults start here vyvanse is not for weight loss. it is not known if vyvanse is safe and effective for treatment of obesity. vyvanse savings offer learn more safety information and side effects learn more about vyvanse proper use of prescription stimulant medication learn more important safety information vyvanse is a federally controlled substance (cii) because it can be abused or lead to dependence. keep vyvanse in a safe place to prevent misuse and abuse. selling or giving away vyvanse may harm others and is against the law. vyvanse is a stimulant medicine. tell the doctor if you or your child have ever abused or been dependent on alcohol, prescription medicines, or street drugs. who should not take vyvanse? do not take vyvanse if you or your child are: taking or have taken an anti-depression medicine called a monoamine oxidase inhibitor (maoi) within the past 14 days. sensitive or allergic to, or had a reaction to other stimulant medicines. serious problems can occur while taking vyvanse. tell the doctor: if you or your child have heart problems, heart defects, high blood pressure, or a family history of these problems. sudden death has occurred in people with heart problems or defects taking stimulant medicines. sudden death, stroke and heart attack have happened in adults taking stimulant medicines. your doctor should check you or your child carefully for heart problems before starting vyvanse. since increases in blood pressure and heart rate may occur, the doctor should regularly check these during treatment. call the doctor right away if you or your child have any signs of heart problems such as chest pain, shortness of breath, or fainting while taking vyvanse. if you or your child have mental (psychiatric) problems, or a family history of suicide, bipolar illness, or depression. new or worse behavior and thought problems or new or worse bipolar illness may occur. new psychotic symptoms (such as seeing or hearing things that are not real, believing things that are not true, being suspicious) or new manic symptoms may occur. call the doctor right away if there are any new or worsening mental symptoms or problems during treatment . if you or your child have circulation problems in fingers and toes (peripheral vasculopathy, including raynaud’s phenomenon). fingers or toes may feel numb, cool, painful, sensitive to temperature and/or change color from pale, to blue, to red. call the doctor right away if any signs of unexplained wounds appear on fingers or toes while taking vyvanse. if your child is having slowing of growth (height or weight). the doctor should check your child’s height and weight often while on vyvanse, and may stop treatment if a problem is found. if you or your child have symptoms of serotonin syndrome: agitation, hallucinations, coma, or changes in mental status; problems controlling movements or muscle twitching, stiffness, or tightness; fast heartbeat; sweating or fever; nausea, vomiting or diarrhea. call your doctor or go to the emergency room if symptoms occur. serotonin syndrome may occur if vyvanse is taken with certain medicines and may be life-threatening. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are breastfeeding or plan to breastfeed. do not breastfeed while taking vyvanse. talk to your doctor about the best way to feed your baby if you take vyvanse. what are possible side effects of vyvanse? the most common side effects of vyvanse in adhd include: anxiety decreased appetite diarrhea dizziness dry mouth irritability loss of appetite nausea trouble sleeping upper stomach pain vomiting weight loss the most common side effects of vyvanse in adults with moderate to severe b.e.d. include: dry mouth trouble sleeping decreased appetite increased heart rate constipation feeling jittery anxiety for additional safety information, click here for prescribing information and medication guide and discuss with your doctor. you are encouraged to report negative side effects of prescription drugs to the fda. visit www.fda.gov/medwatch , or call 1-800-fda-1088. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. if you or your child are pregnant or plan to become pregnant. it is not known if vyvanse may harm your unborn baby. -- site map privacy policy contact us shire us prescribing information medication guide unsubscribe vyvanse is available in capsule form (10, 20, 30, 40, 50, 60, and 70 mg) as well as a chewable tablet (10, 20, 30, 40, 50, and 60 mg). ©2017 shire us inc., lexington, ma 02421. all rights reserved. 1-800-828-2088. shire and the shire logo are registered trademarks of shire pharmaceutical holdings ireland limited or its affiliates. vyvanse and the vyvanse logo are registered trademarks of shire llc. all content of this website, including text, images, graphics, sound files, and their arrangement, belongs to shire and is protected by international copyright laws. all other intellectual property rights are reserved. the content may not be copied for commercial use or distribution, nor may these objects be downloaded, modified, or posted to other sites. this site is intended solely for us residents and is governed solely by us laws and government regulations. please see our online privacy policy for more information. while shire us inc. makes reasonable efforts to include accurate, up-to-date information on the site, shire us inc. makes no warranties or representations as to its accuracy. shire us inc. assumes no liability for any errors or omissions in the content of the site. s38410 04/18 you are about to leave this site please be advi

URL analysis for vyvanse.com

http://www.vyvanse.com/adhd-definition
http://www.vyvanse.com/adhd-questions
http://www.vyvanse.com/adhd-tips
http://www.vyvanse.com/treatment-for-binge-eating-disorder
http://www.vyvanse.com/what-is-adhd
http://www.vyvanse.com/adhd-in-adults-questions
http://www.vyvanse.com/binge-eating-disorder-symptom-checklist
http://www.vyvanse.com/what-is-binge-eating-disorder
http://www.vyvanse.com/adhd-adult-medication
http://www.vyvanse.com/resources-for-adhd
http://www.vyvanse.com/binge-eating-disorder
http://www.vyvanse.com/adhd-in-adults
http://www.vyvanse.com/doctor-discussion-guide-for-adults-with-adhd
http://www.vyvanse.com/doses
http://www.vyvanse.com/site-map

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: VYVANSE.COM
Registry Domain ID: 644626614_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.ascio.com
Registrar URL: http://www.ascio.com
Updated Date: 2017-09-27T21:13:14Z
Creation Date: 2006-10-24T14:42:57Z
Registry Expiry Date: 2018-10-24T14:42:57Z
Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA
Registrar IANA ID: 106
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +442070159370
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
Domain Status: serverTransferProhibited https://icann.org/epp#serverTransferProhibited
Domain Status: serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited
Name Server: DNS.IMC2.COM
Name Server: DNS2.IMC2.COM
Name Server: DNS3.IMC2.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-09-10T15:14:45Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =vyvanse.com

  PORT 43

  TYPE domain

DOMAIN

  NAME vyvanse.com

  CHANGED 2017-09-27

  CREATED 2006-10-24

STATUS
clientTransferProhibited https://icann.org/epp#clientTransferProhibited
serverDeleteProhibited https://icann.org/epp#serverDeleteProhibited
serverTransferProhibited https://icann.org/epp#serverTransferProhibited
serverUpdateProhibited https://icann.org/epp#serverUpdateProhibited

NSERVER

  DNS.IMC2.COM 63.241.253.130

  DNS2.IMC2.COM 52.27.88.167

  DNS3.IMC2.COM 52.200.51.117

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .